跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 134 条关于
“tezepelumab-ekko”
全部
134
临床试验
85
药物
1
机构
2
资讯
46
去年
Tezspire Meets Primary Endpoints in Phase 3 WAYPOINT Trial for Chronic Rhinosinusitis with Nasal Polyps
去年
Nasal Polyposis: Emerging Therapies and Clinical Trial Updates
9个月前
Amgen Secures FDA Approval for IMDELLTRA in Small Cell Lung Cancer as Pipeline Advances Drive Growth
去年
Tezspire Meets Primary Endpoints in Phase 3 WAYPOINT Trial for Chronic Rhinosinusitis with Nasal Polyps
去年
Tezspire Meets Co-Primary Endpoints in Phase 3 Trial for Chronic Rhinosinusitis with Nasal Polyps
去年
Tezepelumab Improves Sleep and Activity in Severe Asthma Patients
9个月前
Monthly Tezepelumab Injection Enables Severe Asthma Patients to Discontinue Daily Steroids
10个月前
Tezepelumab Enables Oral Corticosteroid Reduction in Severe Asthma Patients, WAYFINDER Trial Shows
4个月前
Real-World Study Confirms Tezepelumab Efficacy in Underrepresented Severe Asthma Populations
去年
Tezepelumab Shows Remarkable 92% Reduction in Nasal Polyp Surgery Need in Phase 3 Trial
第 1 页,共 5 页
上一页
下一页